[go: up one dir, main page]

AU2001278154A1 - Drug metabolizing enzymes - Google Patents

Drug metabolizing enzymes

Info

Publication number
AU2001278154A1
AU2001278154A1 AU2001278154A AU7815401A AU2001278154A1 AU 2001278154 A1 AU2001278154 A1 AU 2001278154A1 AU 2001278154 A AU2001278154 A AU 2001278154A AU 7815401 A AU7815401 A AU 7815401A AU 2001278154 A1 AU2001278154 A1 AU 2001278154A1
Authority
AU
Australia
Prior art keywords
metabolizing enzymes
drug metabolizing
drug
enzymes
metabolizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278154A
Inventor
Chandra S. Arvizu
Mariah R. Baughn
Christopher M. Bruns
Narinder K. Chawla
Debopriya Das
Angelo M Delegeane
Li Ding
Vicki S. Elliot
Ameena R. Gandhi
Jennifer A. Griffin
April J. A. Hafalia
Farrah A. Khan
Preeti Lal
Sally Lee
Dyung Aina M. Lu
Yan Lu
Jayalaxmi Ramkumar
Huijun Z. Ring
Madhu S. Sanjanwala
Y. Tom Tang
Kavitha Thangavelu
Michael Thornton
Catherine M. Tribouley
Bridget A. Warren
Junming Yang
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001278154A1 publication Critical patent/AU2001278154A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001278154A 2000-08-04 2001-08-03 Drug metabolizing enzymes Abandoned AU2001278154A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US22305500P 2000-08-04 2000-08-04
US60/223,055 2000-08-04
US22472800P 2000-08-11 2000-08-11
US60/224,728 2000-08-11
US22644000P 2000-08-18 2000-08-18
US60/226,440 2000-08-18
US22806700P 2000-08-24 2000-08-24
US60/228,067 2000-08-24
US23006300P 2000-08-31 2000-08-31
US60/230,063 2000-08-31
US23224400P 2000-09-13 2000-09-13
US60/232,244 2000-09-13
US23426900P 2000-09-20 2000-09-20
US60/234,269 2000-09-20
PCT/US2001/024382 WO2002012467A2 (en) 2000-08-04 2001-08-03 Drug metabolizing enzymes

Publications (1)

Publication Number Publication Date
AU2001278154A1 true AU2001278154A1 (en) 2002-02-18

Family

ID=27569375

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278154A Abandoned AU2001278154A1 (en) 2000-08-04 2001-08-03 Drug metabolizing enzymes

Country Status (5)

Country Link
EP (1) EP1305425A2 (en)
JP (1) JP2004518407A (en)
AU (1) AU2001278154A1 (en)
CA (1) CA2417769A1 (en)
WO (1) WO2002012467A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020098174A1 (en) * 2000-03-31 2002-07-25 Rosana Kapeller-Libermann 33166, a human hydrolase-like molecule and uses thereof
US20030190642A1 (en) * 2000-04-20 2003-10-09 Glenville Jones Thymus expressed human cytochrome p450(p450tec)
DE60128471T2 (en) * 2000-06-29 2008-01-17 Seikagaku Corp. SULFATE TRANSFERASE AND DNA ENCODING THIS ENZYME
WO2002026945A2 (en) * 2000-09-27 2002-04-04 Bayer Aktiengesellschaft Regulation of human aminotransferase-like enzyme
EP1402012A2 (en) 2000-11-30 2004-03-31 Millennium Pharmaceuticals, Inc. Methods of using 18903 to treat pain and pain-related disorders
CA2580336C (en) 2004-07-22 2016-07-19 Roger Kingdon Craig Vh heavy chain only antibodies, and vh heavy chain only dimer compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744355A (en) * 1994-10-18 1998-04-28 Mayo Foundation For Medical Education And Research cDNA cloning and expression of human liver estrogen sulfotransferase
AUPO156596A0 (en) * 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
US5756299A (en) * 1996-12-09 1998-05-26 Incyte Pharmaceuticals, Inc. Human carbonyl reductase
US6060253A (en) * 1997-01-23 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Agents that bind to and inhibit human cytochrome P450 2D6
AU2001265162A1 (en) * 2000-05-26 2001-12-11 Millennium Pharmaceuticals, Inc. 47765, a novel human lysyl oxidase and uses thereof

Also Published As

Publication number Publication date
CA2417769A1 (en) 2002-02-14
JP2004518407A (en) 2004-06-24
WO2002012467A3 (en) 2002-12-27
EP1305425A2 (en) 2003-05-02
WO2002012467A2 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AUPQ899700A0 (en) Probiotic recolonisation therapy
AU2001279134A1 (en) Nucleotide incorporating enzymes
AU7961401A (en) Subtilase enzymes
AU2002357860A1 (en) Enzymes
AU1878601A (en) Enzyme
AU2002220553A1 (en) Bioreactor
GB0006733D0 (en) Enzyme
AU2001227900A1 (en) Drug metabolizing enzymes
AU2001274981A1 (en) Drug metabolizing enzymes
AU2001270303A1 (en) Drug metabolizing enzymes
AU2001262702A1 (en) Coenzyme derivatives and enzymes appropriate therefor
AU2002347778A1 (en) Enzymes
EP1572877A3 (en) Drug metabolizing enzymes
AU2001235000A1 (en) Drug metabolizing enzymes
AU2001255324A1 (en) Drug metabolizing enzymes
AU2002210379A1 (en) Subtilase variants
AU2001264247A1 (en) GASC1 gene
AU2001278154A1 (en) Drug metabolizing enzymes
AU2001247444A1 (en) Erbeta-mediated gene expression
AUPQ749100A0 (en) New epilespy gene
AU2001237592A1 (en) Enzymes and uses relating thereto
AU2001285743A1 (en) Adipose-related gene
AU2001292330A1 (en) Drying-resistant yeast
AU2001294823A1 (en) Hydrolases
AU4367900A (en) Carbohydrate-modifying enzymes